Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
C21 Investments ( (TSE:CXXI) ) has provided an update.
C21 Investments reported a strong financial performance in its second quarter, with a 13% increase in revenue to $8.5 million, driven by a 15% rise in same store sales. Despite a challenging market and a 16% decline in Nevada sales, the company achieved a record number of retail transactions and improved its gross margin to 50.4%. The company’s strategic shift to reduce wholesale exposure and focus on retail sales resulted in a substantial improvement in adjusted EBITDA and positive free cash flow, highlighting its robust business model and growth trajectory.
The most recent analyst rating on (TSE:CXXI) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on C21 Investments stock, see the TSE:CXXI Stock Forecast page.
Spark’s Take on TSE:CXXI Stock
According to Spark, TipRanks’ AI Analyst, TSE:CXXI is a Neutral.
C21 Investments’ overall stock score is primarily influenced by its mixed financial performance and valuation challenges. While there are some positive technical indicators, the negative P/E ratio and lack of dividend yield weigh heavily on the score.
To see Spark’s full report on TSE:CXXI stock, click here.
More about C21 Investments
C21 Investments Inc. is a vertically integrated cannabis company operating in the cannabis industry. The company focuses on retail and wholesale cannabis sales, with a particular emphasis on expanding its retail operations.
Average Trading Volume: 65,528
Technical Sentiment Signal: Buy
Current Market Cap: C$55.94M
Find detailed analytics on CXXI stock on TipRanks’ Stock Analysis page.